Nordea Lifescience Private Limited, a active private limited company, was established on 28 July 2004 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232DL2004PTC127933. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sunaina Jain (Director), Kuldeep Jain (Director). Past directors included Rajeev Jain, Sunaina Jain. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 175, Vardhman Grand Plaza, Plot No. 7, Mangalam Place, Sector-3, Rohini, New De, Lhi-110085, Delhi, Delhi, 110085.
U24232DL2004PTC127933
127933
28 July 2004
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Nordea Lifescience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunaina Jain | Director | 11 Aug 2008 | Current |
| Kuldeep Jain | Director | 28 Jul 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 Aug 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nordea Lifescience Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 100.18% increase. The company also saw a substantial improvement in profitability, with a 96.47% increase in profit. The company's net worth dipped by a decrease of 1.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Nordea Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nordea Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nordea Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nordea Lifescience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nordea Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Nordea Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Sunaina Jain was appointed as a Director was appointed as a Director on 11 Aug 2008 & has been associated with this company since 17 years 3 months . was completed.
Kuldeep Jain was appointed as a Director was appointed as a Director on 28 Jul 2004 & has been associated with this company since 21 years 3 months . was recorded as a recent event.
Nordea Lifescience Private Limited was registered on 28 Jul 2004 with Roc Delhi & aged 21 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Nordea Lifescience Private Limited is U24232DL2004PTC127933.
Nordea Lifescience Private Limited is headquartered at 175, Vardhman Grand Plaza, Plot No. 7, Mangalam Place, Sector-3, Rohini, New De, Lhi-110085, Delhi, Delhi, 110085.
Nordea Lifescience Private Limited was incorporated on 28 July 2004.
The current directors of Nordea Lifescience Private Limited are
The primary industry of Nordea Lifescience Private Limited is Pharma.
Nordea Lifescience Private Limited is unlisted.
The authorized capital of Nordea Lifescience Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nordea Lifescience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX